Treatment challenges and investigational opportunities in autoimmune hepatitis.
about
Clinical features and management of autoimmune hepatitisNon-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment.Difficult treatment decisions in autoimmune hepatitis.Budesonide induces complete remission in autoimmune hepatitisMycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy.Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen/liver pancreas in autoimmune hepatitis.Basic immunosuppressive drugs outside solid organ transplantation.Autoimmune hepatitis. Part B: diagnosis.Current and future treatments of autoimmune hepatitis.Challenges in the diagnosis and management of autoimmune hepatitis.Current Advances in the Treatment of Autoimmune Hepatitis.Advances in the current treatment of autoimmune hepatitis.Drug choices in autoimmune hepatitis: part A--Steroids.Acute and acute severe (fulminant) autoimmune hepatitis.Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study.Evaluation of the revised versus the simplified scoring system in patients with autoimmune hepatitis.Association of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with type 1 autoimmune hepatitis in Japanese.Clinical features of type 1 autoimmune hepatitis in elderly Italian patients.Performance parameters of the diagnostic scoring systems for autoimmune hepatitis.Non-invasive markers of inflammation in autoimmune hepatitis
P2860
Q22305507-5DD7E85B-1160-4CC6-B7A6-5BC412FF0B47Q33447479-5683F11A-E753-403C-B714-4308630A9E42Q33688293-FB42EB4C-2E9D-49E3-A2EB-25076215E7C8Q34012678-FFE72A71-2FCD-4F7B-BD71-3B954AD1AA91Q34286525-8F1E0991-CF26-456A-856E-40317ED82272Q35126088-B562C981-86F7-4CD7-A3E4-6A6AB0C323D3Q36407314-553FE2E0-8460-46D1-B028-97C0DDD1F053Q37346057-9483AF95-D660-4EE3-B01C-126B201A7BAAQ37503380-2348D8E6-DAD7-4510-908B-AC095E74143BQ37640582-C7622137-92DD-4D2C-A38D-3C25D806EE7CQ37678905-6322E00C-734D-4500-BB2E-46C93383F032Q38000056-16C77529-C76D-4F76-8AE9-6AC3970BB6D9Q38051705-5FDB32C1-4CFE-460A-B387-3C70AA2D9429Q38054513-83F0A5E9-C4DD-4BC3-91FD-624CA5F7648DQ40286971-5EF32F29-FAF0-47BA-B841-8833B9B6EB0DQ42009169-81EEE87D-732A-4E13-B8BF-C8E70512145AQ44639109-B3741EE5-44D4-4D8E-BA49-C3A9140AA9ABQ46480408-6659DBAA-9D30-43E0-8D45-80F4D5D5D8E7Q53207120-116EECA0-A0EA-4341-B4E8-13D90AB729D5Q56977372-F8E7D3B4-9C45-4897-8B31-9B054479EE55
P2860
Treatment challenges and investigational opportunities in autoimmune hepatitis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Treatment challenges and investigational opportunities in autoimmune hepatitis.
@ast
Treatment challenges and investigational opportunities in autoimmune hepatitis.
@en
type
label
Treatment challenges and investigational opportunities in autoimmune hepatitis.
@ast
Treatment challenges and investigational opportunities in autoimmune hepatitis.
@en
prefLabel
Treatment challenges and investigational opportunities in autoimmune hepatitis.
@ast
Treatment challenges and investigational opportunities in autoimmune hepatitis.
@en
P2093
P356
P1433
P1476
Treatment challenges and investigational opportunities in autoimmune hepatitis.
@en
P2093
Albert J Czaja
Ansgar W Lohse
Diego Vergani
Edward L Krawitt
Francesco B Bianchi
Giorgina Mieli-Vergani
Gotaro Toda
Herschel A Carpenter
Ian G McFarlane
John Vierling
P304
P356
10.1002/HEP.20539
P407
P577
2005-01-01T00:00:00Z